REPL stock · TSLA stock

REPL vs TSLA · $825.7M cap vs P/E 179, rev $94.83B

Replimune Group Inc (REPL) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.

Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.

Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.

REPL does not have a complete income-statement cache yet.

Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.

REPL currently screens at market cap $825.7M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.

Not investment advice. Open the REPL and TSLA stock pages for the full models.

Not investment advice.

Popular Stock Comparisons